Company intelligence / Profile preview

Youth Biotech

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Youth Biotechnology is a Beijing-based biopharmaceutical company dedicated to developing therapeutics that target the fundamental biological mechanisms of aging. The company utilizes its proprietary AI-driven platform, YouthAI, to identify and optimize small molecule candidates capable of cellular rejuvenation and healthspan extension. Their research focuses on metabolic health, neuroprotection, and age-related muscle loss, with a pipeline of candidates currently in the pre-clinical stage. By combining high-throughput screening with advanced computational biology, Youth Biotechnology aims to translate longevity science into clinical treatments for chronic age-related diseases.

Therapeutic areas: NeurologyOtherMetabolic Disorders
Modalities: Small moleculePeptides
Industry: Biotech

Beyond the preview

Go deeper on Youth Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Youth Biotech.

Explore the full profile